| Financial Year |
March 31 2023 |
| Monetary Funds |
216,945,490.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
49,958,400.18 |
| Advances to Suppliers |
5,187,705.98 |
| Other Receivables |
2,142,179.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
54,146,485.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
170,513,924.70 |
| Total Current Assets |
498,894,186.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,932,096.25 |
| Fixed Assetes |
92,399,049.50 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,389,367.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
65,605.42 |
| Deferred Income Tax Assets |
12,870,528.02 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
142,656,646.53 |
| Total Assets |
641,550,832.96 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
42,122,536.44 |
| Accounts Payable |
57,890,544.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,116,918.18 |
| Taxes Payable |
3,245,858.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,352,713.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
613,561.42 |
| Sub-Total of Current Liabilities |
113,061,836.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
232,004.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
328,512.47 |
| Total Liabilities |
113,390,348.88 |
| Paid-In Capital(Or Share Stock) |
97,217,588.00 |
| Capital Surplus |
341,797,748.84 |
| Surplus Reserve |
17,738,704.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
71,406,442.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
528,160,484.08 |
| Owner's Equity（Stockholder's Equity） |
528,160,484.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
641,550,832.96 |
